Follow
Hallmarks of cancer
The Hallmarks of Cancer comprise a summary of biological processes proposed by Douglas Hanahan and Robert Weinberg in a landmark publication in Cell in 2000. The Hallmarks acquired by cancer included 1) evading apoptosis, 2) self-sufficiency in growth signals, 3) insensitivity to anti-growth signals, 4) sustained angiogenesis, 5) tissue invasion and metastasis, and 6) limitless replicative potential. In XXX, Hanahan and Weinberg updated the hallmarks to include two emerging hallmarks (deregulating cellular energetics and avoiding immune destruction) and two enabling characteristics (genomic instability and mutation and tumor-promoting inflammation).
JUN 16, 2021 | 8:00 AM
Date: June 16, 2021 Time: 8:00am PDT The MACSima™ Imaging Platform is the only complete solution for ultrahigh-content imaging of hundreds of markers, allowing you to understand the tu...
APR 21, 2021 | 5:00 PM
Date: April 21, 2021 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Spatial Answers Trilogy - Spatial Answers in Immunology Immunology Researchers share their Spatial Discoveries in SARS-C...
SEP 17, 2020 | 12:15 PM
Abnormal cellular metabolism is a hallmark of many diseases, yet there is an absence of quantitative methods to dynamically image metabolism with cellular-level resolution. Optical metabolic...
JUL 29, 2020 | 12:00 AM
In this webinar, Dr. Yuting Sun discusses her research supporting a Phase 1 clinical trial advancing cancer therapies, targeted at metabolic vulnerabilities. Metabolic rewiring is a hallmark...
APR 21, 2020 | 1:30 PM
Triple-negative breast cancer (TNBC) is an aggressive disease that accounts for 10-20% of all breast cancer cases diagnosed annually in the U.S.1. Despite its prevalence, TNBC remains resist...
JAN 01, 2020 | 6:00 AM
Accurate DNA replication is essential to transmit the genetic information from one generation to another. However, replication is frequently challenged by barriers that originate from exogen...
JUN 20, 2019 | 1:30 PM
Tumor heterogeneity is a hallmark of cancer and can have significant impact on identifying drivers, including those that may be therapeutically relevant. Although, the traditional sequencing...
OCT 02, 2018 | 9:00 AM
DATE: October 2, 2018TIME: 9:00AM PDTUnderstanding the role of distinct cellular phenotypes in tissue function, development, and pathogenesis requires tools that can rapidly and co...
SEP 20, 2018 | 8:00 AM
DATE: September 20 2018TIME: 11:00am EDT, 5:00pm CEST Cardiovascular disease due to atherosclerosis is the leading cause of disease and mortality worldwide. So-call...
SEP 20, 2018 | 1:00 AM
DATE: September 20, 2018TIME: 10:00am CEST, 4:00pm CST Cardiovascular disease due to atherosclerosis is the leading cause of disease and mortality worldwide. So-called “...
APR 26, 2018 | 8:00 AM
DATE: April 26, 2018TIME: 8:00am PST, 11:00am EST Engineered T cells expressing a tumor antigen-specific receptor have revolutionized the field of cancer therap...
APR 12, 2018 | 10:30 AM
In genomics, as in life, you need to be in the right place at the right time, and you need integrity, to be credible. Since the availability of the human genome sequence, there's been an...
NOV 12, 2014 | 8:00 AM
Dr. Oliver Kepp will be presenting on:Immunogenic cell death fingerprinting utilizing a high-throughput screening approachThe strategy of immunogenic cell death fingerprinting has been design...
OCT 29, 2014 | 1:30 PM
Human malignant glioma is a uniformly fatal disease, causing over 14,000 deaths in the US this year. Adults diagnosed with malignant brain tumors have a median survival of approximately 15 mo...
